Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Waterstone Pharmaceuticals

Request full access

Engaged in the development of various drugs for the treatment of liver and gastrointestinal diseases

Carmel, United StatesFounded 2008Biotech & Life Sciences

About Waterstone Pharmaceuticals

Waterstone Pharma is an international biopharmaceutical company primarily operating in China, dedicated to the discovery, development, and commercialization of innovative drugs targeting significant unmet medical needs, particularly in liver and gastrointestinal diseases. The company serves a global market and is backed by venture capital investments from renowned firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps. Waterstone Pharma has established fully integrated capabilities spanning from research and development (R&D) to active pharmaceutical ingredient (API) and finished drug product manufacturing. The company generates revenue through the commercialization of its therapeutic products, including over forty marketed drugs in China, and is actively involved in clinical trials and preclinical stage antiviral research. Waterstone's strong management team boasts cross-border experience and expertise in drug discovery, regulatory affairs, and good manufacturing practices (GMP), ensuring a robust pipeline of novel therapeutics.

Source: Dealroom company data

At a glance

Status
Operational
Employees
21
Open positions
None listed
Dealroom signal
41.7/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Sep 2020 $61M $244M State Development & Investment Corporation (SDIC) —
DEBTDebt Sep 2012 $19M — Undisclosed —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Waterstone Pharmaceuticals website traffic

Latest recorded traffic for Waterstone Pharmaceuticals is 930 monthly website visits, up 52.5% over the last three months. Waterstone Pharmaceuticals's team grew 5% over the past year.

Latest monthly visits930 3-month web change+52.5% 1-year team growth+5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Waterstone Pharmaceuticals in the Carmel ecosystem

Live from Dealroom

The Waterstone Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • State Development & Investment Corporation (SDIC)
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China66.7%
🇺🇸 United States33.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Waterstone Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Waterstone Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.